Temasek Raises Health-Care Bets, Adds More ADRs of

  • Singapore investment firm buys Illumina, Regeneron, Gilead
  • Firm’s assets rose to record as it boosted investments

Temasek Holdings Pte built holdings of U.S. drugmakers and health-care companies in the first quarter as the Singapore investment firm expands bets on industries that will benefit from rising life expectancies and a growing middle class in emerging markets.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.